Back to Authors
A5080740758 | I145311141
Mayo Clinic
Alnylam Pharmaceuticals (United States)
Neurology | July 25, 2015 | Volume: 85 | Issue: 8 | Pages: 675-682
10.1212/wnl.0000000000001870 | PMID 26208957